David Z. Morris authored an article on Decentralized Autonomous Organizations for funding research for diseases. In the article, our founder and CEO, Alok Tayi, explains how a decentralized science approach can accelerate biotech funding opportunities.
“The obstacle for all of us was that there wasn’t the funding to advance research. The challenge in finding a potential cure is not finding it, it’s funding it … Many of these families are relegated to either the generosity of billionaires or running a bunch of bake sales.”
“Vibe Bio’s founder wasn’t passionate about creating a DAO – but decentralizing drug research could fix a thorny, tragic problem.”
“Rare diseases, though the patient population is small, the economic opportunity is still there,” said Tayi. “Your costs are substantially lower because you don’t need thousands of patients” to conduct studies, for instance.
